Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform

Smart Immune invites you to attend an R&D KOL webinar on Tuesday 28 November 2023 from 5.00pm to 6.30pm CET (11.00am to12.30pm EST).

Karine Rossignol, Co-founder and Chief Executive Officer of Smart Immune, will givean introduction to Smart Immune and its ProTcell platform.

Robert Soiffer, Chairman of the Center for International Blood and Marrow Transplant Research advisory committee, Chief of the Division of Hematologic Malignancies at the Dana-Farber Cancer Institute, and Smart Immune’s Clinical Advisory Board Chairman, will talk about the need to improve allogeneic hematopoietic stem cell transplantation outcomes in daily practice.  

Marina Cavazzana, Co-founder and Strategic Clinical Development Advisor of Smart Immune, will present the ReSET-01 and ReSET-02 trials, including preliminary results in adult acute leukemia patients.

Marcel Van den Brink, Presidentof the City of Hope Los Angles National Medical Center and Chief Physician Executive, and Smart Immune’s Scientific Advisory Board Chairman, will discuss the importance of thymic function in the immune system.

Olivier Negre, Chief Scientific Officer of Smart Immune, will outline preclinical data on the regenerative properties of ProTcell and its potential to unlock allogeneic T-cell medicine.

A Q&A session will follow the presentations.

To register please click here.